hikma pharmaceuticals : Inovio Pharmaceuticals Stock

What’s next for Hikma Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc.?

July 21, 2021adminPricebiohaven pharmaceuticals, hikma pharmaceuticals, inovio pharmaceuticals stock, ligand pharmaceuticals, regeneron pharmaceuticals inc

Regenerun Pharmaceuticals (HIKMA) has agreed to pay a record $1.4 billion to resolve allegations that it withheld favorable research from investors and misled investors in its two flagship medicines.Regeneronne Pharmaceuticals was also ordered to pay $500 million for misappropriating proprietary technology from Hikma.The two firms are in the midst of negotiations with regulators and the…

When is a drug patent expired?

Hulani Pharma, which sells Hepatitis C treatment Sovaldi and other generic drugs, is trying to extend the patents of its products.Hulani filed an application in the U.S. Patent and Trademark Office in December to extend patents of Hepatia and Hepatial (HapT) drugs by three years, which was granted in January.The company is now working on…

Inovio Pharmaceuticals Stock

Tag: hikma pharmaceuticals

What’s next for Hikma Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc.?

When is a drug patent expired?

Sponsorship Levels and Benefits